Review
Recent advancements in biopolymer and metal nanoparticle-based materials in diabetic wound healing management

https://doi.org/10.1016/j.ijbiomac.2018.10.120Get rights and content

Abstract

Currently, diabetes mellitus (DM) accelerated diabetic foot ulcer (DFU) remains vivacious health problem related with delayed healing and high amputation rates which leads to enormous clinical obligation. Keeping in view of the foregoing, researchers have been made in their efforts to develop novel materials which accelerate delayed wound healing in the diabetic patient and reduce the adversative influences of DFUs. The most prominent materials used for the wound healing application have biocompatibility, low cytotoxicity, excellent biodegradable properties, and antimicrobial activity properties. Utilization of nanoparticles has emerged as a protruding scientific and technological revolution in controlling DFUs. Biopolymers in combination with bioactive nanoparticles having antimicrobial, antibacterial, and anti-inflammatory properties have great potential in wound care to enhance the healing process of diabetic wound infectious. Combination of antibacterial nanoparticles like silver nanoparticles (AgNPs), gold nanoparticles (AuNPs), copper nanoparticles (CuNPs) etc. with polymeric matrix could efficiently inhibit bacterial growth and at the same time fastens the healing process of a wound. This review briefed the recent development of different natural polymers and antibacterial nanoparticles to mitigate the diabetes mellitus based DFU.

Introduction

Diabetes mellitus (DM) is a deficiency of insulin secretion and metabolic disorder of multiple etiologies characterized by a chronic proliferation in blood sugar level with distraction in carbohydrate, fat and protein metabolism resulting in the abnormal functioning of insulin in the body. The long-term action of diabetes as shown in Fig. 1 leads to problems such as impaired wound healing and the development of chronic nonhealing foot ulcerations leading to severe depression and mortality [1].

The epidemiological study between the increased number of patients with diabetes mellitus with some selected years is mentioned in the Table 1. According to the estimation, approximately 50%–70% of all the limb amputations are due to diabetic foot ulcer (DFU) and it was reported that in every 30 s, one leg is amputated due to DFU in worldwide [2,3].

Diabetic extremity ulcers developed in approximately 15% of people with diabetes and are the towering cause of hospitalization and amputation in patients [2].

There are 2 different types of wounds i.e. acute wounds including surgical wounds, traumatic wounds, burns which are healed quickly whereas chronic wounds including pressure ulcers, leg ulcers, diabetic foot ulcers, fungating wounds take a longer time to heal [3,6,7].

As reported [[8], [9], [10]], diabetes is subdivided into 4 types: (1) Type 1 diabetes which occurs from autoimmune beta-cell destruction in the pancreas followed by a deficiency of insulin formation, (2) Type 2 diabetes which occurs due to an uncommon upturn in opposing the action of insulin and inability to create required quantity of insulin to overwhelmed this resistance, (3) Gestational diabetes which arises due to glucose intolerance and mostly resulted in females during pregnancy, (4) other diabetes are resulted by specific genetic defects of beta-cell function, illness of the pancreas, drugs or chemicals etc. [11].

Wound healing takes place in four different phases (i) hemostasis phase, (ii) inflammatory phase, (iii) proliferation phase and (iv) remodeling phase. These phases are represented in Fig. 2 and were well explained by various researchers [[12], [13], [14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27]]. As shown in Fig. 2, an acute wound could heal linearly through various healing phases. However, the wound healing process in case of DFU is not as identical as acute wound healing because the healing process may discontinue at any one or more phases. Therefore, it is always recommended to afford a favorable environment to increase the rate of wound healing of DFUs infections and keep away the healing from contamination/infection for a longer period [28,29].

Zhang et al. [31] analyzed that BMI levels were well correlated with DFU and it was suggested that BMI levels of DFU patients are lower than in patients without DFU. Similarly, it was also reported that DFU and retinopathy are very much interconnected [32]. From various studies, it was observed that DFU patients with retinopathy suffered from dysfunctional vasodilation [33], diabetic biomarkers like plasma uric acid and ceruloplasmin in type 2 diabetic patients [[34], [35], [36], [37]].

Therefore, a development in wound healing material which ideally meets the demands of rapid wound closure and complete healing of the wound is a vital issue. An ideal wound healing material should possess several characteristics, as well as conditions at the time of selection such as, it should be cost-effective, biocompatible, non-toxic, low adherence to skin, should provide a moist wound environment, permission of diffusion of gases, thermal insulation (temperature and pH must be controlled), prevention of infection i.e. protection of wound from microorganisms, antibacterial activity [38,39]. Selection of wound healing material is very much subjective because of extreme complications linked to diabetes. The important properties need to consider during the selection of wound healing material are represented in Fig. 3.

The patients with impaired, the hard-to-heal wounds need innovative methods and novel strategies to decrease the infection, accelerating the wound healing process, nourishing the wound, faster wound closing and reducing scar formation. In recent years there has been a rapid increase in drug-resistant microbes and significantly increased resistance to common antibiotics. Therefore, great efforts have been made by researchers for the development of new technologies which could quickly clean the wound from invading bacteria and capable to deliver antibiotics for DFU infections. Among various newly developed technologies, nanotechnology and nanomaterials have been renovating the diagnosis of diabetic wound healing. Biopolymeric materials like cellulose, starch, chitosan, collagen etc., stimulate wound healing by fibrogenesis [[43], [44], [45], [46]]. In recent years, nanoparticles such as silver, gold, and zinc having antibacterial, antibiotic properties along with low in vivo toxicity were contributed an incomparable approach to accelerate the wound healing of delayed acute and chronic wounds. Further, nanoparticle embedded natural polymer based were used as potential wound dressing materials [47]. When nanoparticles incorporated with biopolymeric materials, it acts as a potential wound healing material in the treatment of diabetic ulcer wound.

This review is an attempt to synopsize the potentiality of the natural biopolymers, metal, and metal oxide nanoparticles, and also composite of the biopolymer within the treatment of DFUs infectious.

Section snippets

Pathogenesis of diabetes

Diabetes mellitus (DM) is a clinical syndrome characterized by an increase in blood glucose called hyperglycemia. DM developed by a various biological mechanism called pathogenetic processes which destroy the β cells of the pancreas by an idiopathic autoimmune attack creating insulin insufficiency and others that result in resistance to insulin action [48,49]. Pancreatic β-cells are responsible for controlling the blood glucose level in the body, and disruption of this process will lead to DM [

Materials and strategies used in diabetic wound healing

In order to accelerate the wound healing process, biopolymer and modified biopolymeric materials with essential biocompatibility and improved properties have been developed by researchers [[58], [59], [60], [61], [62], [63]]. The biopolymers help in the physiological activity of the wound healing process. Alginates, collagen, hyaluronic acid and chitosan etc. are used for wound healing of DFUs in the form of nanofibrous bandages, hydrocolloids, hydrogels, gauze, tulle, foam, sprays,

Conclusions

This review is a summarization of a variety of materials that have the future to be used as a composite for the treatment of wound healing of diabetes patients. This has attributed to allowing clinicians to offer them as a new form of medication or adjuncts to prevailing treatments to improve therapeutic effectiveness. There are new promising materials that are currently under development that show great commitments, hence providing hope for new medicinal options in the near future. In this

References (177)

  • M. Gadelkarim et al.

    Adipose-derived stem cells: effectiveness and advances in delivery in diabetic wound healing

    Biomed. Pharmacother.

    (2018)
  • M. Hossen et al.

    Beneficial roles of honey polyphenols against some human degenerative diseases: a review

    Pharmacol. Rep.

    (December 2017)
  • J. Tam et al.

    The in vivo and in vitro diabetic wound healing effects of a 2-herb formula and its mechanisms of action

    J. Ethnopharmacol.

    (2011)
  • S. Kim et al.

    Significance of the presence of autonomic and vestibular dysfunction in diabetic patients with peripheral neuropathy

    Diabetes Metab.

    (2012)
  • C.T. Tsao et al.

    Carbohydr. Polym.

    (2011)
  • M.H. Casimiro et al.

    Int. J. Pharm.

    (2010)
  • S. Ankri et al.

    Antimicrobial properties of allicin from garlic

    Microbes Infect.

    (1999)
  • M.D. Mandal et al.

    Honey: its medicinal property and antibacterial activity

    Asian Pac. J. Trop. Biomed.

    (2011)
  • S.A. Chen et al.

    Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advanced glycation end-products

    Eur. J. Pharm. Sci.

    (2012)
  • K. Blecher et al.

    Nitric oxide-releasing nanoparticles accelerate wound healing in NOD-SCID mice

    Nanomed. Nanotechnol. Biol. Med.

    (2012)
  • N.M. Zain et al.

    Green synthesis of silver and copper nanoparticles using ascorbic acid and chitosan for antimicrobial applications

    Carbohydr. Polym.

    (2014)
  • K. Chaloupka et al.

    Nanosilver as a new generation of nanoproduct in biomedical applications

    Trends Biotechnol.

    (2010)
  • A.D. Widgerow

    Burns

    (2010)
  • R. Singla et al.

    In vivo diabetic wound healing potential of nanocomposites containing bamboo cellulose nanocrystals impregnated with silver nanoparticles

    Int. J. Biol. Macromol.

    (2017)
  • Centers for Disease Control and Prevention

    National Diabetes Statistics Report, 2014 Estimates of Diabetes and Its Burden in the Epidemiologic Estimation Methods

    (2014)
  • American Dietetic Association

    Diabetic foot wound care

    Am. Diabetes Assoc. Diabetes Care

    (April, 1999)
  • R. Nunan et al.

    Clinical challenges of chronic wounds: searching for an optimal animal model to recapitulate their complexity

    Dis. Model. Mech.

    (2014)
  • M.V. Yu et al.

    Department of General Surgery Medical Academy Named After S. I. Georgievskiy, The Federal-State Autonomous Educational Establishment of Higher Education ‘Crimean Federal University Named After V. I. Vernadsky’, Ministry of Education and Science Oft

    (2015)
  • A. Sood et al.

    Wound dressings and comparative effectiveness data

    Adv. Wound Care

    (2014)
  • P. Patel

    A. Macerollo diabetes mellitus: diagnosis and screening

    Am. Fam. Physician

    (2010)
  • R.H. Unger et al.

    Heyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes

    Diabetologia

    (1985)
  • R. Goldenberg et al.

    Definition, classification, and diagnosis of diabetes, prediabetes and metabolic syndrome

    Can. J. Diabetes

    (2013)
  • K. Words

    Role of Collagen In Wound Management

    (2011)
  • G.A. Duque et al.

    Macrophage cytokines: involvement immunity and infectious diseases

    Front. Immunol.

    (2015)
  • T.J. Koh et al.

    Inflammation and wound healing: the role of the macrophage

    Expert Rev. Mol. Med.

    (2011)
  • P. Mohammadreza et al.

    Critical role of transforming growth factor Beta in different phases of wound healing

    Adv. Wound Care

    (2013)
  • E.T. Lauren et al.

    Extracellular matrix and dermal fibroblast function in the healing wound

    Adv. Wound Care

    (2016)
  • P.K. Kristine

    Tissue repair: the hidden drama

    Organ

    (2010)
  • N. Ganapathy et al.

    Molecular biology of wound healing

    Int J Pharm. Bio. Sci

    (2012)
  • J.M. Reinke et al.

    Wound repair and regeneration

    Eur. Surg. Res.

    (2012)
  • Z. Ruilong et al.

    Inflammation in chronic wounds

    Int. J. Mol. Sci.

    (2017)
  • M. Xue et al.

    Extracellular matrix reorganization during wound healing and its impact on abnormal scarring

    Adv. Wound Care

    (2015)
  • T. Cox et al.

    Remodeling and homeostasis of the extracellular matrix: implications for fibrotic disease and cancer

    Dis. Model. Mech.

    (2011)
  • S.M. Mc Carty et al.

    Protease and delayed wound healing

    Adv. Wound Care

    (2013)
  • E. Tsourdi et al.

    Current aspects in the pathophysiology and treatment of chronic wounds in diabetes mellitus

    Biomed. Res. Int.

    (2013)
  • K.L. Thompson et al.

    Nutrition interventions to optimize pediatric wound healing. An evidence-based clinical pathway

    Nutr. Clin. Pract.

    (2014)
  • S. Guo et al.

    Factors affecting wound healing

    J. Dent. Res.

    (2010)
  • M. Jannesari et al.

    Int. J. Nanomedicine

    (2011)
  • P. Zhang et al.

    Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis

    Ann. Med.

    (2017 Mar)
  • S. Potisat et al.

    A 4-year prospective study onlong-term complications of type 2 diabetic patients: the Thai DMS diabetes complications (DD. Comp.) project

    J. Med. Assoc. Thail.

    (2013)
  • Cited by (260)

    View all citing articles on Scopus
    View full text